Brokerages Set Bio-Rad Laboratories, Inc. (NYSE:BIO) Target Price at $327.40
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have earned an average recommendation of “Moderate Buy” from the five research firms that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year […]
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have earned an average recommendation of “Moderate Buy” from the five research firms that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year […]
